VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 715 filers reported holding VANECK VECTORS ETF TR in Q4 2020. The put-call ratio across all filers is 1.18 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $155 | -37.5% | 5,752 | -30.3% | 0.01% | -38.1% |
| Q2 2023 | $248 | -7.1% | 8,252 | 0.0% | 0.02% | -27.6% |
| Q1 2023 | $267 | +12.7% | 8,252 | 0.0% | 0.03% | +3.6% |
| Q4 2022 | $237 | -99.8% | 8,252 | +68.9% | 0.03% | +86.7% |
| Q3 2022 | $118,000 | -11.9% | 4,887 | 0.0% | 0.02% | -6.2% |
| Q2 2022 | $134,000 | -29.5% | 4,887 | -1.3% | 0.02% | -20.0% |
| Q1 2022 | $190,000 | +21.0% | 4,949 | +1.3% | 0.02% | +33.3% |
| Q4 2021 | $157,000 | +9.0% | 4,887 | 0.0% | 0.02% | 0.0% |
| Q3 2021 | $144,000 | -13.3% | 4,887 | 0.0% | 0.02% | -11.8% |
| Q2 2021 | $166,000 | +4.4% | 4,887 | 0.0% | 0.02% | -5.6% |
| Q1 2021 | $159,000 | -9.7% | 4,887 | 0.0% | 0.02% | -14.3% |
| Q4 2020 | $176,000 | -13.3% | 4,887 | -5.8% | 0.02% | -32.3% |
| Q3 2020 | $203,000 | – | 5,187 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Memorial Sloan Kettering Cancer Center | 738,500 | $19,873,035 | 80.92% |
| New Harbor Financial Group, LLC | 1,680,752 | $45,229,033 | 14.96% |
| TORQ CAPITAL MANAGEMENT (HK) Ltd | 139,000 | $3,740,490 | 9.95% |
| Vanderbilt University | 1,360,540 | $36,612,131 | 9.45% |
| Eschler Asset Management LLP | 300,000 | $8,073,000 | 9.42% |
| New Harbor Financial Group, LLC | 1,027,300 | $27,644,643 | 9.15% |
| Guild Investment Management, Inc. | 139,333 | $3,749,454 | 6.28% |
| Monaco Asset Management SAM | 750,000 | $20,182,500 | 5.98% |
| STRATEGIC INVESTMENT MANAGEMENT, LLC | 132,460 | $3,867,832 | 4.74% |
| PCG Wealth Advisors, LLC | 264,614 | $7,120,782 | 4.67% |